The effect of supplementation on reducing depression in children with cancer
Phase 3
Recruiting
- Conditions
- Depression in pediatric patients with malignancy.Mood disorder due to known physiological conditionF06.3
- Registration Number
- IRCT20190202042583N1
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Age between 7 to 18 years
Having malignancy treated with chemotherapy
Not more than one month has passed since the last round of chemotherapy
Do not take antidepressants of any category during the past month
Do not take zinc supplements or other supplements containing zinc compounds during the past month
Satisfaction to test the serum level by taking a blood sample
Regular use of antidepressants or zinc supplements
Exclusion Criteria
Congenital diseases of zinc metabolism such as acrodermatitis enteropathy, chronic inflammatory bowel disease, malabsorption syndromes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression score based on the Mariaquas Children Depression Inventory CDI. Timepoint: day 30. Method of measurement: CDI test.
- Secondary Outcome Measures
Name Time Method